| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |

,

,
*INSERM Unit 99,
Upress B JE 2129, and
Adult Nephrology Service, Henri Mondor Hospital, University of Paris XII, Créteil, France, and
Pediatric Nephrology Service, Armand Trousseau Hospital AP-HP, Paris, France.
Correspondence to Dr. Djillali Sahali, Unité INSERM 99, Hôpital Henri Mondor, AP-HP, 51, avenue du Mal de Lattre-de-Tassigny, 94010, Créteil, France. Phone: 33-1-49-81-35-30; Fax: 33-1-48-98-09-08; E-mail: sahali{at}im3.inserm.fr
ABSTRACT. Clinical and experimental observations suggest that minimal-change nephrotic syndrome (MCNS) results from T cell dysfunction, via unknown mechanisms. For the identification of genes that are potentially involved in MCNS, a subtractive cDNA library was constructed from cDNA from T cell-enriched peripheral blood mononuclear cells obtained from the same patient during relapse versus remission ("relapse minus remission"). This library was screened by differential hybridization with forward ("relapse minus remission") and reverse ("remission minus relapse") subtractive cDNAs probes, as well as unsubtracted probes from relapse and remission, and irrelevant nephrotic syndrome (membranous nephropathy). A total of 84 transcripts were isolated, of which 12 matched proteins of unknown function and 30 were unknown clones. Among the 42 known transcripts, at least 18 are closely involved in the T cell receptor-mediated complex signaling cascade, including genes encoding components of the T cell receptor and proteins associated with the cytoskeletal scaffold, as well as transcription factors. In particular, it was demonstrated that the expression levels of Fyb/Slap, L-plastin, and grancalcin were increased during relapse, suggesting that the integration of proximal signaling after T cell engagement involves the preferential recruitment of these cytoskeleton-associated proteins in MCNS. Because very low levels of interleukin-12 receptor
2 mRNA were detected in relapse samples, the interleukin-12 signaling pathway might be defective, suggesting that, in MCNS, T cell activation evolves toward a T helper 2 phenotype. Therefore, the combination of subtractive cloning and differential screening constitutes an efficient approach to the identification of genes that are likely to be involved in the pathophysiologic processes of MCNS.
This article has been cited by other articles:
![]() |
E. Gonzalez, T. Neuhaus, M. J. Kemper, and E. Girardin Proteomic analysis of mononuclear cells of patients with minimal-change nephrotic syndrome of childhood Nephrol. Dial. Transplant., August 12, 2008; (2008) gfn459v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pardon, V. Audard, S. Caillard, B. Moulin, D. Desvaux, B. Bentaarit, P. Remy, D. Sahali, F. Roudot-Thoraval, P. Lang, et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1053 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
T S Han, M M Schwartz, and E J Lewis Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis Lupus, February 1, 2006; 15(2): 71 - 75. [Abstract] [PDF] |
||||
![]() |
S. Okuyama, A. Komatsuda, H. Wakui, N. Aiba, N. Fujishima, K. Iwamoto, H. Ohtani, and K.-i. Sawada Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome Nephrol. Dial. Transplant., March 1, 2005; 20(3): 539 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Kraft, M. M. Schwartz, S. M. Korbet, and E. J. Lewis Glomerular Podocytopathy in Patients with Systemic Lupus Erythematosus J. Am. Soc. Nephrol., January 1, 2005; 16(1): 175 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Valanciute, S. le Gouvello, B. Solhonne, A. Pawlak, P. Grimbert, L. Lyonnet, S. Hue, P. Lang, P. Remy, R. Salomon, et al. NF-{kappa}B p65 Antagonizes IL-4 Induction by c-maf in Minimal Change Nephrotic Syndrome J. Immunol., January 1, 2004; 172(1): 688 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Grimbert, A. Valanciute, V. Audard, A. Pawlak, S. Le gouvelo, P. Lang, P. Niaudet, A. Bensman, G. Guellaen, and D. Sahali Truncation of C-mip (Tc-mip), a New Proximal Signaling Protein, Induces c-maf Th2 Transcription Factor and Cytoskeleton Reorganization J. Exp. Med., September 2, 2003; 198(5): 797 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Grimbert, V. Audard, P. Remy, P. Lang, and D. Sahali Recent approaches to the pathogenesis of minimal-change nephrotic syndrome Nephrol. Dial. Transplant., February 1, 2003; 18(2): 245 - 248. [Full Text] [PDF] |
||||
![]() |
R. Cunard and C. J. Kelly T Cells and Minimal Change Disease J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1409 - 1411. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673